Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study

Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study

BackgroundMolecular targeted therapy combined with immunotherapy significantly improves the prognosis of patients with advanced liver cancer. Additionally, hepatic arterial infusion chemotherapy (HAIC) can improve the prognosis of patients with advanced liver cancer. This real-world study aimed to e...

Full description

Bibliographic Details
Main Authors: Weihao Zhang, Kai Zhang, Changfu Liu, Wei Gao, Tongguo Si, Qiang Zou, Zhi Guo, Xueling Yang, Mei Li, Dongming Liu, Han Mu, Huikai Li, Haipeng Yu, Wenge Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
hepatic arterial infusion chemotherapy
molecularly targeted agents
advanced hepatocellular carcinoma
conversion surgery
survival benefit
anti-PD-1/PD-L1 immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1127349/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1127349/full

Similar Items